Studies have shown that the overexpresseion of HAS1 in bladder cancer cells can cause an increase in the CD44 variant isoforms (HA receptor), thereby inhibite Fas mediated apoptosis (64), and promoting the growth and invasion of bladder cancer cells. The gene discussed is FAS; the disease is urinary bladder cancer.